The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Taichi MatsubaraGouji ToyokawaKazuki TakadaFumihiko KinoshitaYuka KozumaTakaki AkamineMototsugu ShimokawaAkira HaroAtsushi OsoegawaTetsuzo TagawaMasaki MoriPublished in: PloS one (2019)
EMT and high EZH2 expression were associated with poor NSCLC prognoses. Vimentin is a key factor linking EMT and EZH2 in lung adenocarcinoma.